This big biotech stock doesn't get the hype that SpaceX does. But it could be the smarter bet right now.
Bored Panda on MSN
53 times doctors realized something had gone terribly wrong
Surgeries on the wrong part of the body, medicine administered in the wrong doses, and failures to listen to patients — these ...
DelveInsight's Pharmacogenomic Testing Service Market Insights report provides the current and forecast market analysis, individual leading pharmacogenomic testing service companies' market shares, ...
3don MSN
23andMe owes customers money again: Who’s eligible for the new $47 million bankruptcy payment
The genetic testing company had a major data breach in 2023 and filed for Chapter 11 in 2025. The 23andMe hacking saga has a ...
The pharmacogenomic testing service market is witnessing strong growth, driven by the increasing adoption of personalized medicine and the growing recognition of genetic factors in drug response.
Researchers have validated a genetic scoring tool that may help physicians diagnose idiopathic pulmonary fibrosis and ...
WIND GAP, Pa. — Genetic testing for medical purposes is known to be expensive, but a new community health research program is now offering lifesaving answers for free. When 38-year-old Nick Lumi first ...
Alex Murdaugh's defense wants Othram, the DNA lab that helped crack the Bryan Kohberger case, to test unknown male DNA found ...
By Jonathan Stempel July 7 (Reuters) - A U.S. bankruptcy judge on Tuesday approved a $46.75 million settlement for victims of ...
3don MSN
Gene-edited babies are now closer to becoming a reality. The ethical debate is far from settled
New research shows it’s possible to edit the DNA of human embryos with more precision. But scientists warn it’s still not ...
A United States bankruptcy judge ordered genetic testing company 23andMe to pay a nearly $50 million settlement for a 2023 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results